Literature DB >> 12601456

The impact of the International Subarachnoid Aneurysm Treatment Trial (ISAT) on neurosurgical practice.

K W Lindsay.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12601456     DOI： 10.1007/s00701-002-1066-7

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN： 0001-6268            Impact factor:   2.216


× No keyword cloud information.
  5 in total

1.  Surveillance of intracranial aneurysms treated with detachable coils: a comparison of MRA techniques.

Authors:  Richard I Farb; Shudeshna Nag; James N Scott; Robert A Willinsky; Thomas R Marotta; Walter J Montanera; George Tomlinson; Karel G Terbrugge
Journal:  Neuroradiology       Date:  2005-06-10       Impact factor: 2.804

2.  Endovascular Treatment of Complex Intracranial Aneurysms With LEO+ Stents: The LEO II Cohort Study.

Authors:  Omer F Eker; Olivier Levrier; Emmanuel Houdart; Marianne Bonja; Denis Herbreteau; Alain Bonafé; Hubert Desal
Journal:  Front Neurol       Date:  2022-06-28       Impact factor: 4.086

3.  Endovascular versus operative treatment of cerebral aneurysms: a comparison of results from a low-volume neurosurgical centre.

Authors:  Gorazd Bunc; Janez Ravnik; Matjaz Vorsic; Tomaz Seruga; Marko Jevsek; Tomaz Smigoc; Tomaz Velnar
Journal:  Wien Klin Wochenschr       Date:  2015-12-10       Impact factor: 1.704

4.  China Intracranial Aneurysm Project (CIAP): protocol for a prospective cohort study of interventional treatment and craniotomy for unruptured aneurysms.

Authors:  Yunchang Chen; Haiyan Fan; Xuying He; Shenquan Guo; Xifeng Li; Min He; Yan Qu; Xinjian Yang; Hongqi Zhang; Xiaochuan Sun; Liqun Wang; Zhong Wang; Xiaoguang Tong; Ming Zhong; Aisha Maimaitili; Zhiyong Tong; Chuanzhi Duan
Journal:  BMJ Open       Date:  2018-05-24       Impact factor: 2.692

5.  Four-year trends in the treatment of cerebral aneurysms in Poland in 2009-2012.

Authors:  Tomasz Tykocki; Kacper Kostyra; Marcin Czyż; Bogusław Kostkiewicz
Journal:  Acta Neurochir (Wien)       Date:  2014-02-06       Impact factor: 2.216
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.